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     BSTRACT
Pyothorax is a rare disease in cats. Underlying causes and treatment recommendations vary 
greatly between cases. In this case series, the management of two challenging cases of feline 
pyothorax is discussed. In the first case, a nine-year-old female spayed European shorthair cat 
with pyothorax caused by Bacteroides fragilis is described. At the time of presentation, she was 
diagnosed with feline immunodeficiency virus as well. The pyothorax was succesfully managed 
medically. Unfortunately, the cat relapsed after three months and the owner elected euthanasia. 
The second case involved a ten-year-old male castrated British shorthair cat with identification 
of filamentous bacteria on pleural fluid cytology. This cat underwent surgical intervention be-
cause thoracic drainage was very difficult. Eventually, he recovered well and did not relapse up 
to two months postoperatively. The challenges in the decision process and treatment complica-
tions are discussed.
SAMENVATTING
Pyothorax is een aandoening die niet vaak voorkomt bij katten. De onderliggende oorzaken en 
behandelingskeuze variëren sterk naargelang het geval. In het voorliggende artikel worden twee uitda-
gende casussen van pyothorax bij de kat besproken. In de eerste casus wordt een vrouwelijke, gester-
iliseerde Europese korthaar van negen jaar met pyothorax ten gevolge van Bacteroides fragilis bespro-
ken. Bij presentatie van de kat op de Faculteit Diergeneeskunde (UGent) werd bij het dier bovendien 
het feliene immunodeficiëntie virus gediagnosticeerd. De pyothorax werd succesvol behandeld met 
medicamenteuze therapie, maar de kat herviel drie maanden nadien en werd geëuthanaseerd. In de 
tweede casus wordt een mannelijke, gecastreerde Britse korthaar van tien jaar beschreven, waarbij op 
het cytologisch onderzoek van de pleurale effusie filamenteuze bacteriën geïdentificeerd werden. De 
kat onderging een chirurgische ingreep, herstelde uiteindelijk goed en vertoonde geen tekenen van 
recidief tot twee maanden postoperatief. De uitdagingen bij het maken van belangrijke beslissingen en 
de complicaties tijdens de behandeling worden besproken.
A
INTRODUCTION
Pyothorax is characterized by an accumulation 
of septic exudate in the thoracic cavity (Ettinger and 
Feldman, 2010). Most commonly, oropharyngeal flo-
ra is isolated in the pleural fluid (Walker et al., 2000; 
Demetriou et al., 2002). While infection of the thoracic 
cavity through penetrating bite wounds or parapneu-
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monic spread after aspiration of oropharyngeal flora, 
e.g. after dental procedures, seem to occur most often 
in cats, the underlying cause remains unknown in 30-
65% of cases (Waddell et al., 2002; Barrs et al., 2005; 
MacPhail, 2007; Barrs and Beatty, 2009a). The treat-
ment approach of pyothorax remains controversial, 
but can be broadly divided into two groups: medical 
and/or surgical management. Medical treatment usu-
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ally includes broad spectrum antibiotic treatment and 
thoracic drainage through thoracostomy tubes and of-
ten provides a good outcome in uncomplicated cases. 
In contrast, surgical treatment should be considered 
in cases that respond inadequately to the placement 
of thoracostomy tubes, in cases with isolation of fila-
mentous bacteria in the pleural fluid, in cases of sus-
picion of or confirmed foreign body, and in cases with 
medical treatment failure after 2-7 days (Demetriou et 
al., 2002; Barrs et al., 2005; Monnet, 2009; Boothe et 
al., 2010; Murphy and Papasouliotis, 2011a; Stillion 
and Letendre, 2015). In this article, two cases of feline 
pyothorax are reported, enabling a thorough discus-
sion of the differences between medical and surgical 
management and several factors influencing the clini-
cian’s decision process. The cat described in the first 
case tested positive for feline immunodeficiency vi-
rus (FIV). The compromised immune status of the cat 
required special measures to overcome pleural infec-
tion. In the pleural fluid of the second case, filamen-
tous bacteria were isolated, complicating the general 
approach due to the associated pyogranulomatous re-
action. The isolation of filamentous bacteria is one of 
the most common indications for early surgical inter-
vention in pyothorax. 
CASE 1
A nine-year-old female spayed European short-
hair cat was presented at the referring veterinarian 
with chronic complaints of dyspnea, weight loss and 
lethargy and complete anorexia for three days. Upon 
examination, the cat had a fever. Antibiotics and non-
steroidal anti-inflammatory drugs were initiated, but 
without clinical improvement. The following day, a 
thoracocentesis was performed due to muffled lung 
sounds on auscultation. Thick, yellow fluid was as-
pirated and the cat was referred (day 0) to the Small 
Animal Department, Faculty of Veterinary Medicine 
(Ghent University) for further diagnostic work-up and 
treatment.
Upon admission, the cat reacted aggressively to 
manipulation. She was tachypneic (70/min) and pre-
sented with an inspiratory dyspnea without stridor. 
Lung auscultation was muffled ventrally on both 
sides, but more pronounced on the left hemithorax. 
The remaining vital parameters were within normal 
limits. The cat showed mild muscle atrophy and se-
vere dental plaque, tartar and gingivitis. The left eye 
showed remnants of an infection with feline herpes 
virus (FHV) as a kitten. The cat was kept strictly in-
doors, but the other cat in the household was allowed 
to go outside, and both cats did not get along very 
well. 
The cat was admitted to the intensive care unit 
and supplemented with humidified oxygen in an oxy-
gen cage. Quick in-house cytological evaluation of 
the pleural fluid provided by the referring veterinar-
ian suggested pyothorax, based on the macroscopic 
appearance of the effusion and the presence of de-
generated neutrophils and suspicion of intracellular 
bacteria on cytology. An intravenous (IV) catheter 
was placed and the cat was sedated with butorpha-
nol (Dolorex®, Intervet International BV, Boxmeer, 
the Netherlands; 0.4 mg/kg IV), dexmedetomedine 
(Dexdomitor®, Orion Corporation, Espoo, Finland; 
3 µg/kg IV) and midazolam (Dormicum®, NV Roche 
SA, Brussels, Belgium; 0.2 mg/kg IV). Afterwards, 
propofol (Propovet Multidose®, Zoetis Belgium SA, 
Louvain-la-Neuve, Belgium) was administered IV to 
effect, to allow placement of bilateral thoracic drains 
(Surgivet® Pneumothorax Set (10 Fr); Smiths Medi-
cal ASD Inc., Minnesota, United States of America). 
About 290 mL of pleural effusion was removed and 
correct positioning of the chest tubes was radiograph-
ically evaluated (Figures 1A and 1B). Thoracic radio-
graphs did not reveal significant changes of the lung 
Figures 1A and B. Control radiographs after the placing of bilateral thoracic drains in the cat of the first case. The 
right drain ends at the level of the fifth rib and was advanced slightly further afterwards. The left drain correctly ends 
at the level of the second rib. There is a moderate amount of pleural effusion present, characterized by the rounded 
lung lobes and the soft tissue opacity silhouetting with the heart.
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field. The aspirated fluid grossly appeared yellow 
and opaque with large amounts of flocculent mate-
rial. Pleural fluid cytology revealed a high cellular-
ity, predominantly consisting of severely degenerated 
neutrophils and macrophages. Many extracellular and 
intracellular rod-shaped bacteria were present, con-
firming the suspected pyothorax. Total protein and to-
tal nucleated cell count (TNCC) were not performed 
since cytological examination was sufficient for diag-
nosis. A sample of the pleural effusion was submitted 
for aerobic and anaerobic culture. 
A complete blood count (CBC) and serum bio-
chemistry profile were performed, showing mild, 
non-regenerative anemia, mild lymphocytosis, severe 
neutropenia, pseudothrombocytopenia and slightly 
elevated urea (Table 1). Blood smear revealed moder-
ate neutrophilia with left shift. The neutropenia seen 
on CBC can be explained as a laboratory error, in 
which the automated cell counts probably miscounted 
band neutrophils as lymphocytes. Given that the cat 
belonged to a multi-cat household with a history of 
intercat aggression, additional testing for feline im-
munodeficiency virus (FIV) and feline leukemia virus 
(FeLV) was performed (SNAP® COMBO FeLV Ag/
FIV Ab TEST KIT, Idexx Laboratories Inc., Maine, 
United States of America); the cat tested positive for 
FIV.
During the evening, the respiratory rate decreased 
to acceptable limits (36 to 44 breaths/min), the dys-
pnea resolved and the oxygen supplementation was 
stopped. The cat received maintenance fluid therapy 
(Sterofundin B®, B. Braun Melsungen AG, Melsun-
gen, Germany; 70 mL/kg/day IV) as well as Hart-
mann’s infusion (Vetivex Hartmann’s Solution®, 
Dechra Limited, Staffordshire, United Kingdom; 35 
mL/kg/day IV) for rehydration and to compensate 
for loss of fluids through thoracic drainage. The chest 
tubes were emptied every four hours and thoracic la-
vage with Hartmann’s solution was performed every 
eight hours (initially 10 mL/kg, thereafter 20 mL/kg). 
Antibiotic therapy was initiated with amoxicillin-
clavulanic acid (Augmentin®, GlaxoSmithKline Phar-
maceuticals SA/NV, Waver, Belgium; 20 mg/kg q8h 
IV) and enrofloxacine (Baytril 2.5%®, Bayer SA/NV, 
Diegem, Belgium; 5 mg/kg q24h SC). Buprenorphine 
(Vetergesic®, Alstoe Limited, York, United Kingdom; 
10 µg/kg q8h IV) was initiated for pain management.
On day 1, the cat remained mildly tachypneic but 
the lung sounds were less muffled. The general con-
dition was improved, but the cat remained anorexic. 
Omeprazole (Losec®, AstraZeneca SA/NV, Brussels, 
Belgium; 1 mg/kg q24h IV) was initiated. The tho-
racic drains were still highly productive with a total 
of 34.6 mL/kg/day. 
Table 1. Blood results of both cases at presentation (day 0).
 Case 1 Reference values case 1 Case 2 Reference values case 2
Erythrocytes 5.66 6.54 – 12.2 x 1012/L 4.44 5.00 – 10.00 x 1012/L
Hematocrit 23.1 30.3 – 52.3 % 22.9 30.0 – 45.0 %
Hemoglobin 8.1 9.8 – 16.2 g/dL 10.7 9.0 – 15.1 g/dL
MCV 40.8 35.9 – 53.1 fL 51.6 41.0 – 58.0 fL
MCH 14.3 21.2 – 25.9 pg 24.2 12.0 – 20.0 pg
MCHC 35.1 28.1 – 35.8 g/dL - 29.0 – 37.5 g/dL
RDW 23.1 15 – 27 % 20.9 17.3 – 22.0 %
Leukocytes 11.75 2.87 – 17.02 x 109/L 38.01 5.50 – 19.50 x 109/L
Neutrophils 0.88 1.48 – 10.29 x 109/L 33.59 2.50 – 12.50 x 109/L
Lymphocytes 8.40 0.92 – 6.88 x 109/L 1.00 0.40 – 6.80 x 109/L
Monocytes 2.42 0.05 – 0.67 x 109/L 1.58 0.15 – 1.70 x 109/L
Basophils 0.03 0.01 – 0.26 x 109/L 0.10 0.00 – 0.10 x 109/L
Eosinophils 0.02 0.17 – 1.57 x 109/L 1.74 0.10 – 0.79 x 109/L
Platelets 19 151 – 600 x 103/µL 835 175 – 600 µL x 103
Reticulocytes 1.1 3 – 50 x 103/µL 49.5 10 – 110 µL x 103
    
Urea 14.3 5.7 – 12.9 mmol/L 8 5.7 – 12.9 mmol/L
Creatinine 67 71 – 212 µmol/L 69 71 – 212 µmol/L
Total protein 66 57 – 89 g/L 60 57 – 89 g/L
Albumin 24 23 – 39 g/L 18 23 – 39 g/L
Globulin 42 28 – 51 g/L 42 28 – 51 g/L
ALT 21 12 – 130 U/L 101 12 – 130 U/L
ALP 14 14 – 111 U/L 37 14 – 111 U/L
Total bilirubin - - 77 0 – 15 µmol/L
Glucose 6.8 3.95 – 8.84 mmol/L 7.24 3.95 – 8.84 mmol/L
Sodium 149 150 – 165 mmol/L 161 150 – 165 mmol/L
Potassium 4 3.5 – 5.8 mmol/L 4.7 3.5 – 5.8 mmol/L
Chloride - - 122 112 – 129 mmol/L
MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; RDW = 
red cell distribution width; ALT = serum alanine transferase activity; ALP = serum alkaline phosphatase activity.
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Over the next days, the cat’s respiratory pattern 
normalized. Repeated pleural fluid cytology revealed 
decreasing numbers of neutrophils, macrophages and 
intracellular bacteria. By day 3, chest tube production 
had decreased to 6.4 mL/kg/day and bacteria were 
only rarely detected on pleural fluid cytology. Unfor-
tunately, the cat’s good clinical response coincided 
with more aggressive behavior, which was an impor-
tant factor in the cat’s further management. The cat 
was sedated with butorphanol (Dolorex®; 0.3 mg/kg 
IV) and both thoracic drains were removed. Because 
the cat still showed poor appetite, a naso-esophageal 
feeding tube was placed and tube feeding was started. 
On day 4, bacteriological culture of the pleural fluid 
came back positive for Bacteroides fragilis, sensi-
tive to amoxicillin-clavulanic acid, and enrofloxacine 
was discontinued. Biochemistry was repeated and 
revealed normalization of the serum urea concentra-
tion. The cat regained appetite and was discharged 
on day 5 with amoxicillin-clavulanic acid (Kesium®, 
SOGEVAL, Laval, France; 20 mg/kg q12h PO) for a 
minimum of four weeks. 
Recheck thoracic radiographs were advised one 
week after discharge, but the cat was presented two 
weeks later. At this point, she was still on antibiotics 
and showed no clinical signs of recurrence. She was 
eating well and had no respiratory complaints. On 
physical examination, there was neither tachypnea nor 
dyspnea. Auscultation of the lung field was normal, 
but a systolic heart murmur of 2/6 was detected at the 
level of the sternum. Due to the cat’s uncooperative 
behavior, only one lateral view was performed and 
revealed pleural fissure lines, most likely indica-ting 
thickening of the pleura (scar tissue) associated with 
the pyothorax (Figure 2). The antibiotics were con-
tinued until the next control visit two to three weeks 
later. Echocardiography was offered, but declined by 
the owner. 
Further follow-up was performed by the referring 
veterinarian. The antibiotic therapy was prolonged for 
several additional weeks and the cat remained clini-
cally stable. Unfortunately, three months after dis-
charge, pyothorax recurred. The owners decided not 
to treat again and the cat was euthanized.
CASE 2
A ten-year-old male castrated British shorthair cat 
was presented to the referring veterinarian for detar-
tration. Afterwards, he was lethargic and completely 
anorexic for two days. He remained partially anorexic 
Figure 2. Right lateral thoracic radiograph of the Euro-
pean shorthair cat two weeks after discharge, showing 
marked improvement of the pleural effusion. There are 
some pleural fissure lines present, most likely indicating 
thickening of the pleura due to scar tissue.
Figure 3. A.  Right lateral and B. dorsoventral thoracic radiographs of the cat of the second case, showing very severe 
pleural effusion, more pronounced in the left hemithorax. The cardiac silhouette is masked by the soft tissue opacity 
of the free fluid and the trachea is displaced dorsally. The lungs are severely displaced caudodorsally on the lateral 
projection. There is an alveolar pattern present in the right cranial lung lobe. 
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over the following three weeks and lost 600 grams. 
At that point, tachypnea, dyspnea and a fever of 40°C 
were identified. The cat received tolfenaminic acid 
(Tolfedine® 4%, Vétoquinol BV, ‘s-Hertogenbosch, 
Belgium; 4 mg/kg IM) and cefovecin (Convenia®, Zo-
etis Belgium SA, Louvain-La-Neuve, Belgium; 8 mg/
kg IM), without improvement. Two days later, thorac-
ic radiographs revealed the presence of mainly left-
sided pleural effusion. Only a small amount of thick 
fluid was removed by thoracocentesis. Therefore, the 
cat was referred (day 0) to the Small Animal Depart-
ment of the Faculty of Veterinary Medicine (Ghent 
University).
Physical examination revealed tachypnea with se-
vere dyspnea – mainly inspiratory – without stridor, 
tachycardia and lethargy. Muffled lung- and heart 
sounds were auscultated, especially on the left hemi-
thorax. The cat had pale pink mucous membranes 
with normal capillary refill time, and femoral pulses 
were weak. The blood pressure (BP), measured with 
the Doppler ultrasonic technique, was within normal 
limits (96 mmHg). CBC and serum biochemistry re-
vealed mild, non-regenerative anemia, moderate leu-
kocytosis, consisting of moderate neutrophilia and 
mild eosinophilia, mild thrombocytosis, moderate 
hypoalbuminemia and marked hyperbilirubinemia 
(Table 1). After stabilization with humidified oxygen 
delivered through a face mask, thoracic radiographs 
showed severe pleural effusion with asymmetric dis-
tribution, more pronounced in the left hemithorax. An 
alveolar pattern in the left cranial lung lobe was sus-
pected, but this was to be re-evaluated after removal 
of the pleural fluid (Figures 3A and 3B).
Bilateral thoracocentesis was performed, remo-
ving 50 mL of thick, yellow pus containing flocculent 
material. On cytology, the pleural fluid showed a high 
cellularity and contained mostly degenerate neutro-
phils with smaller numbers of macrophages and areas 
of necrotic material. These findings were consistent 
with a purulent exudate. Large clusters of filamentous 
Figure 4. Hematoxylin and eosin stain of the pleural fluid 
of the British shorthair cat, showing large clusters of 
filamentous bacteria and large amounts of degenerated 
neutrophils and macrophages.
Figure 5. Intraoperative images showing A. a large 
amount of thick, pleural effusion with flocculent and fi-
brinous material B. left hemithorax with collaps of the 
lung lobes, covered with fibrinous material and C. a se-
verely reactive and thickened mediastinum.
organisms confirmed the diagnosis of pyothorax (Fig-
ure 4). The cat was sedated with fentanyl (Fentadon®, 
Dechra, Bladel, the Netherlands; 5 µg/kg IV) and a 
local intercostal block was performed with lidocaine 
(Xylocaïne® 2%, AstraZeneca BV, Zoetermeer, the 
Netherlands; 4 mg/kg) to allow the placement of two 
thoracic drains. About 200 mL of red-brownish fluid 
with flocculent material was removed over the next 
ten hours, but drainage remained difficult. The cat 
was hospitalized and was started on crystalloid infu-
sion (Vetivex Hartmann’s Solution®; 90 mL/kg/24h), 
amoxicillin-clavulanic acid (Augmentin®; 20 mg/kg 
q8h IV) and enrofloxacine (Baytril 2.5%®; 5 mg/kg 
q24h IV). For analgesia, buprenorphine (Vetergesic®; 
20 μg/kg q6h IV) was administered.
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The next day (day 1), the cat remained tachypneic 
with mild inspiratory dyspnea and muffled lung 
sounds. Because drainage through the thoracic drains 
was difficult and filamentous bacteria were seen on 
cytology, the cat underwent an exploratory sternoto-
my. He received fentanyl (Fentadon®, Dechra, Bladel, 
the Netherlands; 5 µg/kg IV) as premedication, and 
anesthesia was induced with alfaxalone (Alfaxan®, Ju-
rox (UK) Limited, Worcestershire, United Kingdom; 
3 mg/kg IV) and maintained with isoflurane (IsoFlo®, 
Zoetis Belgium SA, Louvain-La-Neuve, Belgium) 
vaporized in oxygen using a rebreathing system, com-
bined with a constant rate infusion (CRI) of fentanyl 
(Fentadon®, Dechra, Bladel, the Netherlands; 5 µg/
kg/h IV). Inspection of the pleural cavity showed a 
large quantity of thick, yellow fluid. In the left hemi-
thorax, all lung lobes were collapsed and covered with 
fibrous material. The right hemithorax showed no col-
lapsed lung lobes, but adhesions between the lung and 
the parietal pleura were present. The mediastinum 
was severely reactive and thickened and was removed 
for the most part (Figure 5). Samples for aerobic and 
anaerobic bacteriologic and histologic examination 
were taken and submitted to the lab. A new thoracic 
drain was placed and secured with a Chinese finger 
trap suture. An esophageal feeding tube was placed 
to ensure adequate nutritional support. Additionally, 
a fentanyl patch (Duragesic®, Janssen Pharmaceutica 
Products, L.P., New Jersey, United States of America) 
was placed onto shaved and cleaned skin to provide 
analgesia during hospitalization.
Thoracic radiographs were taken to ensure the cor-
rect placement of the esophageal feeding tube as well 
as the thoracic drain. Postoperatively, the cat suffered 
from severe hypotension (BP of 74 mmHg), and se-
rum biochemistry revealed severe hypoalbuminemia 
(Table 2). He received two boluses of colloids (HAES-
steril 6%®, Fresenius Kabi NV/SA, Schelle, Belgium; 
2.5 mL/kg IV) and was placed on a CRI of colloids 
(HAES-steril 6%®; 0.8 mL/kg/h IV). Because the blood 
pressure (BP) did not improve, a CRI of norepine- 
phrine (Levophed®, Hospira Benelux BVBA, Ant-
werp, Belgium; 0.1 μg/kg/min IV) was started. After 
gradually increasing the dose to 0.18 μg/kg/min, the 
BP increased to normal values (90-92 mmHg). The 
thoracic drain was emptied every four hours and a 
total of 68 mL (15.1 mL/kg/day) was collected on 
day 1. Buprenorphine was replaced by methadone 
Table 2. Follow-up blood results during the hospitalization of case 2.
 Day 2 Day 3 Day 4 Day 5 Day 7 Day 9 Reference values
Erythrocytes 3.37 4.36 5.26 5.42 5.01 5.26 5.00 – 10.00 x 1012/L
Hematocrit 17.6 22.6 27.3 28.6 26.0 26.5 30.0 – 45.0 %
Hemoglobin 6.5 9.6 9.5 10.4 9.7 9.7 9.0 – 15.1 g/dL
MCV 52.2 51.9 51.9 52.8 51.8 50.4 41.0 – 58.0 fL
MCH 19.3 22.1 18.2 19.3 19.3 18.4 12.0 – 20.0 pg
MCHC 37.0 - 35.0 36.5 37.3 36.5 29.0 – 37.5 g/dL
RDW 19.6 20.0 18.7 19.1 19.4 20.3 17.3 – 22.0 %
Leukocytes 60.3 56.48 36.99 27.76 33.34 29.94 5.50 – 19.50 x 109/L
Neutrophils 54.72 50.22 31.91 24.41 30.03 20.37 2.50 – 12.50 x 109/L
Lymfocytes 0.41 0.48 1.03 0.88 0.51 0.72 0.40 – 6.80 x 109/L
Monocytes 2.75 3.94 2.20 1.22 1.48 1.24 0.15 – 1.70 x 109/L
Basophils 0.23 0.09 0.20 0.16 0.22 0.19 0.00 – 0.10 x 109/L
Eosinophils 2.19 1.76 1.65 1.09 1.10 2.42 0.10 – 0.79 x 109/L
Platelets 403 642 524 575 434 783 175 – 600 x 103/µL
Reticulocytes 41.1 33.5 40.8 82.7 34.0 58.7 10 – 110 x 103/µL
       
Urea - - - - 2.5 - 5.7 - 12.9 mmol/L
Creatinine 69 74 - - 73 - 71 – 212 µmol/L
Total protein 43 56 - - 65 - 57 – 89 g/L
Albumin 10 16 17 - 20 22 23 – 39 g/L
Globulin 33 40 - - 45 - 28 – 51 g/L
ALT - - - - 116 - 12 – 130 U/L
ALP - - - - 135 - 14 – 111 U/L
Total bilirubin 63 62 - 46 - - 0 – 15 µmol/L
Glucose - - - - 7.43 - 3.94 – 8.83 mmol/L
Sodium 156 159 158 - 163 161 150 – 165 mmol/L
Potassium 4.3 3.3 3.7 - - 4.5 3.5 – 5.8 mmol/L
Chloride 125 120 118 - 120 117 112 – 129 mmol/L
Phosphorus - - 1.49 1.71 - - 1.00 – 2.42 mmol/L
MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; RDW = 
red cell distribution width; ALT = serum alanine transferase activity; ALP = serum alkaline phosphatase activity.
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(Comfortan®, Eurovet Animal Health BV, Bladel, the 
Netherlands; 0.3 mg/kg q4h IV) until sufficient activ-
ity of the fentanyl patch could be reached and meloxi-
cam (Metacam®, Boehringer Ingelheim Vetmedica 
GmbH, Ingelheim/Rhein, Germany; 0.1 mg/kg SID 
SC) was added to the therapy. 
On day 2, the BP decreased again (75-84 mmHg). 
Therefore, meloxicam was not repeated, and the CRI 
of norepinephrine was increased to 0.22 μg/kg/min. 
Blood examination revealed persistent hypoalbumine- 
mia and more severe anemia (Table 3). A compa- 
tible whole blood transfusion was administered with-
out complications. During the day, a total of 86 mL 
(20.2 mL/kg/day) of pleural effusion was collected. 
The neutrophils still showed signs of degeneration, 
but less than on the initial smears. The macrophages 
were strongly vacuolated. Only a few rod-shaped in-
tracellular bacteria were seen, but no more chains of 
filamentous bacteria were present. Tube feeding was 
started in the evening. Methadone was discontinued, 
further therapy remained the same. 
The next day (day 3), the hypoalbuminemia and 
anemia had slightly improved (Table 3). Because 
the cat developed hypokalemia, the Hartmann infu-
sion was supplemented with potassium (Kali-Ste-
rop®, Laboratoria STEROP NV; Brussels, Belgium; 
30 mEq/L). The CRI of colloids and norepinephrine 
could be decreased gradually while maintaining nor-
mal BP, and both were discontinued eventually. The 
total amount of pleural effusion aspirated decreased 
to 28 mL (6.4 mL/kg/day). 
On day 4, thoracic radiographs showed small rem-
nants of pleural effusion, but an iatrogenic pneumo-
thorax was caused, because the three way-stop valve 
got detached. Fortunately, this was quickly resolved. 
The hypokalemia normalized and the potassium sup-
plementation was stopped. The hypoalbuminemia, 
anemia and leukocytosis kept on improving and total 
aspirated pleural fluid decreased to 18 mL (3.9 mL/
kg/day) (Table 3). The pleural fluid had a lower cellu-
larity than the days before and no more bacteria were 
seen. Despite the cytological presence of filamentous 
organisms, bacterial culture after three days of growth 
came back negative. Histological examination re-
vealed reactive proliferations, most likely in response 
to bacterial antigens, with rod-shaped bacteria in a 
single area. No filamentous bacteria were seen and 
acid-fast stains were negative. 
During the following days, the cat remained sta-
ble, but calm and anorexic. On day 5, the thoracic 
drain was removed and on day 6, the antibiotics were 
changed from intravenous to oral administration. En-
rofloxacine (Xeden®, SOGEVAL, Laval, France; 5 
mg/kg SID PO) and amoxicillin clavulanic acid (Cla-
vubactin®, Le Vet BV, Oudewater, the Netherlands; 
12.5 mg/kg BID PO) were administered. The Hart-
mann infusion was continued at maintenance rate. 
The next day (day 7), definitive bacterial cultures 
came back negative as well. It was decided to add 
trimethoprim-sulphadiazine (Tribrissen®, Intervet In-
ternational BV, Boxmeer, the Netherlands; 15 mg/kg 
SID PO), because the clinical condition of the cat did 
not improve sufficiently, suggesting ongoing infec-
tion despite negative culture results. Afterwards, the 
cat became more active. Blood results improved fur-
ther and thoracic radiographs were repeated on day 9, 
which showed improvement of the atelectasis of the 
left cranial lung lobe and little remaining pleural effu-
sion (Table 2; Figures 6A and 6B). 
The cat was discharged on oral antibiotics (enro- 
floxacine, amoxicillin clavulanic acid and thrimetho- 
prim-sulphadiazine), and feeding through the esopha-
geal feeding tube were continued at home. Fortunately, 
the cat quickly started eating spontaneously at home 
Figure 6A. Lateral and B. dorsoventral thoracic radiographs of the British shorthair cat on day 9. The radiographs 
show improvement of the atelectasis of the left cranial lung lobe, which had previously been seen. A left-shift of the 
mediastinum and the cardiac silhouette is still present due to remaining decreased volume of the left lung. A focal area 
of pleural effusion persists at the level of the left costodiaphragmatic angle.
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and the esophageal feeding tube could be removed. 
Two months after discharge, the cat was active, had 
a good appetite and had already gained some weight. 
Recheck thoracic radiographs were taken by the re-
ferring veterinarian, which showed no more pleural 
effusion and further improvement of the atelectasis of 
the left lung lobes. Unfortunately, the cat was lost to 
further follow-up.
DISCUSSION
In this article, both medical and surgical treat-
ments of pyothorax in cats are discussed based on the 
description of two different cases. It is obvious that 
the treatment approach should be adjusted according 
to each individual case. The first case showed no im-
mediate indication for surgical intervention. Medical 
treatment was started and the cat rapidly responded. 
The second case was diagnosed with a more complex 
pyothorax from the beginning, characterized by in-
adequate drainage through thoracostomy tubes and 
cytological detection of filamentous bacteria. It was 
quickly decided that surgical exploration would be 
necessary to provide a good outcome. Not all cases of 
pyothorax are this clearly divided into those that need 
surgery and those that do not. Therefore, all cases of 
pyothorax should undergo thorough work-up, mini-
mally consisting of thoracic radiographs after fluid 
drainage and cytological evaluation and bacteriologi-
cal culture of the pleural fluid, to assess whether or not 
any complicating factors could be present (MacPhail, 
2007). 
Although in case 1, straightforward medical treat-
ment of pyothorax is described, the treatment ap-
proach was in fact complicated by the FIV-positive 
status of the cat. An association between pyothorax 
and FIV-positive cats could be expected, given that 
both can be attained through bite wounds. Moreover, 
the immuosuppression caused by FIV might be a 
predisposing factor for bacterial infections, possibly 
leading to pyothorax. Currently, no direct relation-
ship between pyothorax and FIV seems to be present. 
The prevalence of FIV in cats with pyothorax seems 
to be low (1.5%), although only 50 of 128 affected 
cats have actually been tested (Demetriou et al., 2002; 
Waddell et al., 2002; Barrs et al., 2005). Given that 
the cat was only diagnosed with FIV at presentation 
for pyothorax, it is difficult to assess the influence of 
FIV on the pleural space disease process. The anam-
nesis did not reveal any relevant medical history, but 
the acute phase of infection with FIV, characterized 
by transient sickness, often goes unnoticed by the 
owners. This suggests that at presentation, the cat was 
either in the subclinical phase of FIV-infection, under-
going progressive immunosuppression, or in the ter-
minal phase, with the bacterial infection of the pleural 
space as an opportunistic infection (Sykes, 2014a). 
The cat in this case responded well to conser-
vative treatment, consisting of analgesia, thoracic 
drainage with lavage and antibiotic therapy. Initially, 
amoxicillin-clavulanic acid and enrofloxacine were 
administered. In light of increasing antibiotic resis-
tance, it would have been better to initiate therapy 
with amoxicillin-clavulanic acid or amoxicillin only, 
given that the obligate anaerobic bacteria most fre-
quently isolated from pyothorax in cats, are often sus-
ceptible to penicilline derivates (Walker et al., 2000; 
Demetriou et al., 2002; Barrs et al., 2005; Barrs and 
Beatty, 2009b). However, the veterinary clinicians in 
this case report take increasing antibiotic resistance 
into consideration through the use of de-escalation 
therapy, i.e. discontinuation of ineffective antibio- 
tics after susceptibility testing or based on clinical re-
sponse (Weese et al., 2015). In human medicine, de-
escalation therapy has been successfully used in or-
der to minimize antibiotic resistance and no negative 
impact on clinical condition has been seen (Gonzalez 
et al., 2013; Mokart et al., 2014). In the cat of this 
case report, the isolated bacteria were susceptible to 
amoxicillin-clavulanic acid and therefore, enrofloxa-
cine was discontinued. By doing so, the development 
of antibiotic resistance might have been be minimized 
(Weese et al., 2015).
In the literature, there is no general consensus as to 
when thoracic drains are ideally removed in cases of 
pyothorax. Most commonly, drain removal is advised 
when fluid production is declining, cytological evi-
dence of infection resolution is present and the patient 
is responding well clinically. Ideally, bacterial culture 
results should confirm appropriate antibiotic therapy 
prior to removal (Demetriou et al., 2002; Klainbart 
et al., 2007; Barrs and Beatty, 2009b; Marques et al., 
2009; Murphy and Papasouliotis, 2011b). Several ex-
ternal factors took part in the decision to prematurely 
remove the drains in this case. The cat was difficult 
to manipulate, especially regarding thoracic drainage 
and lavage, and the owners were financially limited. 
Given that drain production was low, clinical response 
was good and significant cytological improvement of 
infection was seen, the thoracic drains were removed 
in spite of few bacteria still being present on cytology 
of the pleural fluid. In this case, the results of culture 
and susceptibility testing were not available yet, to 
confirm appropriate antibiotic treatment.
This case sets a good example for treating FIV-
positive cats. Although these cats are more suscepti-
ble to opportunistic infections, they may be as capable 
as FIV-negative cats in fighting infections. However, 
it might be necessary to prolong antibiotic therapy 
or to treat more aggressively to enable full recovery 
(Hosie et al., 2009). In one case, a cat tested positive 
for FIV when being presented for recurrence of pyo-
thorax (Demetriou et al., 2002). It can be suggested 
that there is a link between FIV and recurrence rates, 
but data supporting this belief are insufficient and 
recurrence is a known complication of pyothorax in 
cats, regardless of the immune status (Demetriou et 
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al., 2002; Waddell et al., 2002; Boothe et al., 2010). 
In the cat of this case report, the pyothorax relapsed 
three months after discharge, but it remains uncertain 
whether this can be attributed to the FIV-positive sta-
tus of the cat.
In case two, a complex example of pyothorax in 
cats caused by filamentous organisms is described. 
Filamentous bacteria most commonly isolated in pyo-
thorax include Actinomyces spp. and Nocardia spp. 
(Demetriou et al., 2002; Waddell et al., 2002; Barrs 
et al., 2005). Most commonly, Nocardia spp. are ac-
id-fast whereas Actinomyces spp. are not. However, 
when the infecting strain of Nocardia is not acid-fast, 
differentiation between both may be difficult (Sykes, 
2014b). Although Nocardia spp. are usually not dif-
ficult to isolate on most routine bacteriologic media 
(Saubolle and Sussland, 2003), the culture results 
came back negative, hence, definitive diagnosis and 
susceptibility testing were not possible in this case. In 
this case, acid-fast stains on the histological samples 
came back negative, but the cat was suspected to be 
infected with Nocardia spp. based on poor response to 
initiated antibiotic therapy. Nocardia spp. are gram-
positive filamentous saprophytes that are found in 
dust, organic material and water. Infection occurs 
through inhalation or through inoculation of skin 
wounds. Nocardiosis is often seen as an opportunistic 
infection in immunocompromised patients (Malik et 
al., 2006; Sykes, 2014b). The cat in case 2 did not un-
dergo FIV/FeLV-testing because he was strictly kept 
indoors and had no contact with other cats, making in-
fection unlikely. There were no reasons to assume that 
the cat was immunocompromised. Typically, nocardi-
osis is divided into three clinical syndromes: cutane-
ous, pulmonary and disseminated nocardiosis (Malik 
et al., 2006; Sykes, 2014b). In pulmonary nocardio-
sis, infection most likely occurs through inhalation, 
and intra- and/or extrapulmonary masses are formed, 
possibly leading to pyothorax (Sykes, 2014b). In this 
case, it is important to acknowledge dental procedures 
as a possible underlying cause of pyothorax. In most 
cases of pyothorax, oropharyngeal flora is isolated. 
These bacteria can be aspirated during dental proce-
dures (Demetriou et al., 2002; Barrs et al., 2005). This 
cat had recently undergone detartration, but it was 
difficult to confirm a causal relationship. Actinomyces 
spp. may form part of the normal oropharyngeal flora 
in cats, whereas Nocardia spp. do not (Walker et al., 
2002; Barrs et al., 2005). 
Pyothorax caused by filamentous organisms gene-
rally does not respond well to medical therapy because 
of the associated pyogranulomatous inflammatory re-
sponse, complicating sufficient drainage of the pleu-
ral exudate (Sivacolundhu et al., 2001; Malik et al., 
2006). In this case, drainage through thoracostomy 
tubes was indeed very difficult. Thoracic radiographs 
revealed an alveolar pattern, and computed tomogra-
phy (CT) was proposed to the owners to provide more 
detailed information regarding the cause. The own-
ers did not consent to this scan and decided on early 
exploratory surgery instead. The performed media-
stinectomy was necessary to enable adequate thoracic 
drainage, which is one of the cornerstones of success-
ful treatment of pyothorax (Piek and Robben, 2000; 
Rooney and Monnet, 2002; Boothe et al., 2010).
Postoperatively, the cat in case 2 did not recover 
without complications. The cat developed severe 
hypotension. In cats with pyothorax, this is most com-
monly seen due to the development of sepsis (Brady 
et al., 2002). Most common complications after tho-
racic surgery include pain and/or wound dehiscence 
and discharge. Postoperative hypotension has not 
been thoroughly described, but recovery after thoracic 
surgery seems to be more guarded for cats than for 
dogs (Moores et al., 2007; Tilson, 2016). In general, 
the mortality rates of cats and dogs undergoing tho-
racic surgery vary according to underlying disease, 
with an intermediate survival rate (60-70%) for cats 
and dogs undergoing thoracic surgery for pleural ef-
fusion (Bellenger et al., 1996; Tilson, 2016). Severe 
complications, including death, seem to be associated 
more often with the underlying cause than with the 
surgery itself (Moores et al., 2007). Postoperatively, 
the cat in case two was hemodynamically unstable 
and the prognosis did seem more guarded at that time 
point. Intensive treatment with fluid therapy and vaso- 
pressors was necessary to gradually restore normal 
blood pressure. Only after two days, the colloids and 
norepinephrine could be discontinued and the cat was 
able to maintain normal blood pressure. Meloxicam 
was administered for perioperative pain management, 
when blood pressure was normalized. The use of non-
steroidal anti-inflammatory drugs in a hypotensive 
patient is contraindicated because of the increased 
risk of adverse reactions, such as renal injury. Such 
drugs should be used cautiously in the presence of 
hypotension (Berry, 2015; Hunt et al., 2015). There-
fore, when the blood pressure lowered again later on, 
meloxicam was discontinued. Further, on day 4, iatro-
genic pneumothorax was caused through detachment 
of the three-way stop valve while taking thoracic con-
trol radiographs. Luckily, there were no other injuries 
to the thoracic cavity, the intrathoracic air was quickly 
evacuated through the intact thoracic drain and the cat 
did not suffer from any consequences afterwards. The 
long-term presence of thoracostomy tubes is not with-
out risk. It has been reported that cats with chest tubes 
develop a variety of complications in over half of 
cases, ranging from local irritation to nerve damage, 
hemorrhage and pneumothorax (Barrs et al., 2005). 
It was difficult to assess appropriate antibiotic 
therapy in this case, because there was no culture or 
susceptibility testing to account for. When there is a 
suspicion of Nocardia spp., first-choice antibiotics 
consist of trimethoprim-sulfonamides (TMS), but 
these are often disguarded due to the potential side 
effects, such as nausea, anorexia and myelosuppres-
sion, which may occur when treating at high dosages 
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for a long period of time, which is usually required for 
the treatment of pyothorax (Malik et al., 2006; Sykes, 
2014b). Further, different strains of Nocardia spp. re-
spond to different types of antibiotics and a broad-
spectrum approach is for that reason often initiated 
instead. Studies in cats have shown that antimicrobial 
resistance of the most common strains of Nocardia 
to fluoroquinolones and amoxicillin-clavulanic acid is 
high and therefore, both should not be recommended 
for treating nocardiosis (Malik et al., 2006; Govendir 
et al., 2011). While waiting for culture results, the an-
tibiotic therapy of the case discussed above initially 
consisted of the combination of amoxicillin-clavu- 
lanic acid and enrofloxacine. Although this is not the 
first choice for treating nocardiosis, it is generally 
effective for the treatment of other bacteria causing 
pyothorax, including Actinomyces spp. (Sivacolund-
hu et al., 2001; Rooney and Monnet, 2002; MacPhail, 
2007). Unfortunately, nocardiosis could never be con-
firmed. The culture results came back negative and re-
peated cultures were not performed as it was unlikely 
to yield positive results after treatment with broad-
spectrum antibiotics for several days. The insufficient 
improvement of the clinical condition of the cat raised 
suspicion and after six days, TMS were added to the 
therapy. According to de-escalation therapy, amoxi-
cillin-clavulanic acid and enrofloxacine should have 
been discontinued and replaced by TMS (Weese et al., 
2015). The lack of culture and susceptibility testing 
in this case made it difficult to safely adjust antibiotic 
therapy. Therefore de-escalation therapy was not ap-
plied. Furthermore, it is difficult to attribute the pro-
gression of the clinical condition to the initiation of 
TMS, because clinical improvement of nocardiosis is 
often only seen after approximately seven days of an-
tibiotic treatment (Sykes, 2014b). 
After discharge, the cat recovered well and was 
treated with long-term antibiotics. The cat did not 
show any signs of recurrence two months after dis-
charge. It is not clear for how long the antibiotic 
therapy was prolonged and if all antibiotics were con-
tinued long-term. Nocardiosis usually has a guarded 
long-term prognosis because of high recurrence rates 
(Malik et al., 2006). Data concerning the appropriate 
duration of antibiotic treatment of pyothorax caused 
by Nocardia spp. in cats is scarce. The total duration 
of antibiotic treatment should be three to six months, 
but it may be required for up to a year to prevent the 
patient from relapsing (Sivacolundhu et al., 2001; 
Malik et al., 2006; Yildiz and Doganay, 2006). 
CONCLUSION
In this case series, one case of pyothorax that was 
medically managed and one case that required surgi-
cal treatment are described. These two cases show 
that treatment approach should always be assessed 
individually in order to provide a good outcome and 
that challenges occur in cats with pyothorax. Recur-
rence is a common complication of pyothorax, which 
was of significant importance in the first case, describ-
ing pyothorax in an immunocompromised patient. In 
this case, prolongation of antibiotic therapy should 
be advised. The second case involved filamentous 
bacteria, causing an intrathoracic pyogranulomatous 
inflammatory response. Antibiotic therapy should be 
long-term in this case as well. In both cases, there was 
no clear consensus as to when the antibiotic therapy 
could be safely terminated.
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